Document is current

Any future updates will be listed below

Author Correction: Combination gemcitabine and PD-L1xCD3 bispecific T cell engager (BiTE) enhances T lymphocyte cytotoxicity against cholangiocarcinoma cells

Crossref DOI link: https://doi.org/10.1038/s41598-025-88644-7

Published Online: 2025-02-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark